Modified PAGE-B score classifies HCC risk in patients undergoing HBV therapy

The PAGE-B score and a modified PAGE-B score identified which patients on antiviral therapy for chronic hepatitis B had a low risk for hepatocellular carcinoma development, according to published data.Because the PAGE-B score — a risk prediction model based on age, sex, and platelet count — was developed among Caucasian patients on HBV antiviral therapy, Terry Cheuk-Fung Yip, PhD, from the Chinese University of Hong Kong, and colleagues developed the mPAGE-B score, modified slightly by Korean investigators to include serum albumin and weighted adjustment of age, sex, and plateletRead More

Share on facebook
Share on twitter
Share on linkedin